PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

Novai publishes study supporting use of DARC imaging technology to identify patients at risk of central vision loss from macular atrophy

Study published in 'Expert Review of Ophthalmology' demonstrates potential to predict both speed and direction of macular atrophy progression at an earlier stag...
Continue Reading →
news

South Korea’s dry eye market to see intensified competition with third homegrown drug approval, says GlobalData

South Korea's Ministry of Food and Drug Safety has approved recoflavone (Latica/Recodu) for moderate to severe dry eye disease. Developed jointly by GL PharmaTec...
Continue Reading →
news

Astoriom Acquires Additional UK Storage Business to Expand Capacity and Service Offerings

·       Acquisition of Sampled’s UK facility strengthens Astoriom’s position as a trusted provider of secure, compliant and qu...
Continue Reading →
news

AlphaRose Therapeutics Awarded Multi-Million Dollar SBIR Fast Track Grant to Advance AI-Generated Therapy, Rosiphersen, for Bain Syndrome

AlphaRose Therapeutics, a pioneer in precision genetic medicine, announced it has been awarded National Institute of Health's (NIH) Small Business Innovation Res...
Continue Reading →
news

Shionogi Announces European Commission Approval of Zokovea® (ensitrelvir) for Post-Exposure Prophylaxis of COVID-19

Zokovea becomes the first oral antiviral medicine authorized in the European Union for the post-exposure prophylaxis of COVID-19* Approval is based on the Ph...
Continue Reading →
news

CDMOs invest in European API capabilities to balance changing demand and supply chain risks, says GlobalData

Contract development and manufacturing organisations (CDMOs) are ramping up their active pharmaceutical ingredient (API) investments in Europe. A series of recen...
Continue Reading →
news

DFE Pharma to showcase its Continuous Manufacturing Platform at CPHI Milan 2026

The platform supports pharmaceutical companies in developing, evaluating and optimising formulations and processes for continuous manufacturing. DFE Pharm...
Continue Reading →
news

Nuclera appoints Carl Raimond as Chief Executive Officer

Former Olink Proteomics President brings extensive life-science tools leadership experience, having helped lead Olink through its $3.1 billion acquisition by Th...
Continue Reading →
news

Orange strengthens its life sciences innovation ecosystem with investment in French health-tech start-up Biolevate      

◼  Investment by Orange Ventures reinforces Orange's commitment to French Tech and trusted innovation in healthcare ◼  Orange Business com...
Continue Reading →
news

Ryvu Therapeutics Reports 2026 Half-Year Financial Results and Provides Corporate Update

Romaciclib in relapsed or refractory acute myeloid leukemia: On August 26, Ryvu dosed the first patient in the expansion cohort of approximately 30 patients wit...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC